5 results about "Agmatine" patented technology

The invention relates to a method for obtaining crystallised foetal bovine serum by adding agmatine that, at a specific concentration, acts to increase cell production and increase protein expression

The application belongs to the field of genetic engineering and biological catalysis, and discloses an arginine decarboxylase mutant derived from Bacillus licheniformis and application of the arginine decarboxylase mutant in production of agmatine. The application takes wild-type arginine decarboxylase BLSpeA of Bacillus licheniformis DW2 as a parent, and obtains a mutant BLspeA with improved catalytic performance through site-directed mutagenesis A157V . The results show that the mutant BLspeA A157V of the application has an efficiency of 68.13% in converting L-arginine into agmatine in a catalytic system, which is about 19% higher than that of the wild-type arginine decarboxylase, indicating that the mutant has potential superiority in producing agmatine and has good industrial application prospect.

The application relates to the field of biotechnology and discloses a method for enhancing the white powdery disease resistance of wheat. The application also discloses the application of agmatine and a solution thereof in improving the white powdery disease resistance of wheat, wherein the concentration of the agmatine is 5-200 micromoles per liter. The method for enhancing the white powdery disease resistance of wheat is simple in operation and low in cost.

A solid supplement composition comprising at least one non-ester nitrate compound and at least one isolated amino acid compound, wherein the at least one isolated amino acid compound is agmatine, wherein the at least one isolated amino acid compound is a separate compound than the at least one non-ester nitrate compound, and wherein the solid supplement composition comprises an amount of nitrate ion (NO3—) that is at least about 0.05625 mg. A semisolid supplement composition comprising at least one non-ester nitrate compound and at least one isolated amino acid compound, wherein the at least one isolated amino acid compound is agmatine, wherein the at least one isolated amino acid compound is a separate compound than the at least one non-ester nitrate compound, and wherein the semisolid supplement composition comprises an amount of nitrate ion (NO3—) that is at least about 0.05625 mg.

The present invention relates to a method for obtaining crystallized fetal bovine serum by adding agmatine, which has the effect of increasing cell production and increasing protein expression per cell at a specific concentration. Furthermore, the method, with respect to a specific reconstitution form into a liquid, is shown for use without losing its original properties, allowing for storage without a cryogenic chain, reducing the risk of contamination, and enabling precise dosage.